The role of polymorphisms in the IGF-I gene in aging and age-related diseases

Autor: Jamjl Janssen

Publikováno v: Experimental and Clinical Endocrinology & Diabetes. 112

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c9e9fa79078f23ff572d5011fc008c5b
https://doi.org/10.1055/s-2004-832867

Ultra-processed foods and type 2 diabetes: more fundamental research is needed.

Autor: Janssen JAMJL; Department of Internal Medicine, Erasmus MC, Dr Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands.

Publikováno v: The Lancet regional health. Europe [Lancet Reg Health Eur] 2024 Sep 19; Vol. 46, pp. 101084. Date of Electronic Publication: 2024 Sep 19 (Print Publication: 2024).

The Impact of Westernization on the Insulin/IGF-I Signaling Pathway and the Metabolic Syndrome: It Is Time for Change.

Autor: Janssen JAMJL; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, 3015 GD Rotterdam, The Netherlands.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 25; Vol. 24 (5). Date of Electronic Publication: 2023 Feb 25.

New Insights into the Role of Insulin and Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Metabolic Syndrome.

Autor: Janssen JAMJL; Department of Internal Medicine, Erasmus Medical Center, Room Rg527, 3015 GD Rotterdam, The Netherlands.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Jul 25; Vol. 23 (15). Date of Electronic Publication: 2022 Jul 25.

Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer Cells.

Autor: Berk Ş; Department of Molecular Biology and Genetics, Faculty of Science, Sivas Cumhuriyet University, Sivas, Turkey.; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands., Janssen JAMJL; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands., van Koetsveld PM; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands., Dogan F; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands., Değerli N; Department of Molecular Biology and Genetics, Faculty of Science, Sivas Cumhuriyet University, Sivas, Turkey., Özcan S; Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkey.; Department of Biology, Faculty of Sciences, Erciyes University, Kayseri, Turkey., Kelestimur F; Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkey.; Yeditepe University, Faculty of Medicine, Istanbul, Turkey., Hofland LJ; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands.

Publikováno v: Frontiers in oncology [Front Oncol] 2021 Jul 05; Vol. 11, pp. 645732. Date of Electronic Publication: 2021 Jul 05 (Print Publication: 2021).